TrademarkDir
TUMOUR DEFENCE BREAKER
DEAD

Serial Number

87367645

Owner

Helix BioPharma Corp

Attorney

Cheryl S. Scotney

Filing Date

Mar 11, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TUMOUR DEFENCE BREAKER Trademark

Serial Number: 87367645 • Registration: 5929639

TUMOUR DEFENCE BREAKER is a trademark filed by Helix BioPharma Corp on March 11, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Helix BioPharma Corp (3 trademarks)

305 Industrial Pkwy S. #3
Aurora, Ontario L4G3V7 , CA

Entity Type: 03

Trademark Details

Filing Date

March 11, 2017

Registration Date

December 10, 2019

Published for Opposition

September 24, 2019

Cancellation Date

June 26, 2026

Goods & Services

Medicinal and pharmaceutical preparations and substances, namely, anti-cancer preparations; pharmaceutical and medicinal preparations and substances for the diagnosis, treatment, alleviation and/or prevention of cancer

Reagents for medical, biological and pharmaceutical research use

Filing History

CANCELLED SEC. 8 (6-YR)
Jun 26, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 10, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 21, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 21, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 21, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 21, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 21, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 2, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 14, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 14, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 14, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 13, 2019 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 11, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 11, 2018 GNSL
SUSPENSION LETTER WRITTEN
Dec 11, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 3, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 5, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 5, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 5, 2018 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 4, 2018 RCCK
ASSIGNED TO LIE
Jun 3, 2018 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 18, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 18, 2017 GNSL
SUSPENSION LETTER WRITTEN
Nov 18, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 6, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jun 6, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jun 6, 2017 CNRT
ASSIGNED TO EXAMINER
Jun 6, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2017 NWOS
NEW APPLICATION ENTERED
Mar 15, 2017 NWAP

Related Trademarks

More from this Owner

HELIX BIOPHARMA CORP. logo

HELIX BIOPHARMA CORP.

Trademark logo

Serial #75230891